NewAmsterdam Touts Cholesterol Drug Success, But Results Trail Analysts' Expectations
NewAmsterdam said Monday its experimental drug lowered "bad" LDL cholesterol But the results were below biotech stock analysts' views. The post NewAmsterdam Touts Cholesterol Drug Success, But Results Trail Analysts' Expectations appeared first on Investor's Business Daily.
NewAmsterdam said Monday its experimental drug lowered "bad" LDL cholesterol But the results were below biotech stock analysts' views.
The post NewAmsterdam Touts Cholesterol Drug Success, But Results Trail Analysts' Expectations appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
